Newsletter Subject

🌐 The World's First "$20 Trillion Drug?" /May 12, 2024

From

bullishstocktrader.com

Email Address

insights@bst.bullishstocktrader.com

Sent On

Sun, May 12, 2024 11:23 PM

Email Preheader Text

One small biotech holds the key to a revolution in treating Alzheimer's disease. The World's First "

One small biotech holds the key to a revolution in treating Alzheimer's disease. The World's First "$20 Trillion Drug?" [DNA]( One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! [Get the name of the stock here ]( All the best, Simmy Adelman, Publisher Behind the Markets Stock Trader is committed to delivering exclusive opportunities to our valued readers. We strongly recommend giving careful consideration to the message above from one of our trusted business partners. Experiencing issues or have questions? Contact [our support team](mailto:support@bullishstocktrader.com), available 24/7, to guide you every step of the way. Stock Trader sending this newsletter on behalf of Event Horizon LLC. 435 N Dupont Hwy, Dover, DE 19901, United States Copyright © 2024 Stock Trader. All Rights Reserved. [Logo]( [Privacy Policy]( [Terms Conditions]( [Unsubscribe](

Edit & Download HTML

Add To Favourites

EDM Keywords (14)

world stock revolution one newsletter name message key high guide gets disease committed behalf anyone

bullishstocktrader.com

Lloyd Davidson from Stock Trader

Marketing emails from bullishstocktrader.com

View More
Sent On

26/05/2024
Sent On

26/05/2024
Sent On

26/05/2024
Sent On

25/05/2024
Sent On

25/05/2024
Sent On

25/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.